GENTAMICINE PANPHARMA 40 mg, solution for injection ampoule, 2 ml
Active ingredients: Gentamicin, Gentamycin sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionampoule, 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GENTAMICINE PANPHARMA 40 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Nov 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63720680CIP73269524CIP133400932695249Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GENTAMICINE (SULFATE DE)solution | — | SA |
| GENTAMICINEsolution | 40 mg · 2 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.